It agonizes two receptors simultaneously: GLP-1 and GIP, the other major incretin hormone
If you're on Medicare and have been waiting for a window to explore GLP-1 treatment, this year may be the right time to start that conversation
Hormonal shifts during perimenopause and menopauseparticularly the drop in estrogen, progesterone, and DHEAcreate a cascade of changes in the body: Slower metabolism (especially after age 40) Increased insulin resistance Visceral fat accumulation (around the belly and midsection) Disrupted sleep and cortisol imbalance Loss of lean muscle mass This isnt just about appearance
GLP-1 receptor agonists like semaglutide are primarily approved for type 2 diabetes and weight management, but emerging research suggests metabolic dysregulation and chronic inflammation may play roles in endometriosis severity
[129] The National Association of Boards of Pharmacy, a trade organization for pharmacy regulators, claims that there are tens of thousands of online pharmacies operating illegally or outside of the association's recommendations
Statistical analysis The results are expressed as means s.e.m